NOWDiagnostics

Bentonville, United States Founded: 2013 • Age: 13 yrs
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
Request Access

About NOWDiagnostics

NOWDiagnostics is a company based in Bentonville (United States) founded in 2013.. NOWDiagnostics has raised $65.69 million across 5 funding rounds from investors including LabCorp, DigitalDX Ventures and Kompass Kapital. The company has 28 employees as of December 31, 2022. NOWDiagnostics has completed 2 acquisitions, including Cellmic and ZBx Corporation. NOWDiagnostics offers products and services including First To Know® Syphilis Test, ADEXUSDx® hCG Test, and First To Know® Pregnancy Test (EU). NOWDiagnostics operates in a competitive market with competitors including OpGen, Avails Medical, Resistell, HandyLab and GNA Biosolutions, among others.

  • Headquarter Bentonville, United States
  • Employees 28 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nowdiagnostics Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $65.69 M (USD)

    in 5 rounds

  • Latest Funding Round
    $22.5 M (USD), Series B

    Jul 09, 2024

  • Investors
    LabCorp

    & 2 more

  • Employee Count
    28

    as on Dec 31, 2022

  • Investments & Acquisitions
    Cellmic

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NOWDiagnostics

NOWDiagnostics offers a comprehensive portfolio of products and services, including First To Know® Syphilis Test, ADEXUSDx® hCG Test, and First To Know® Pregnancy Test (EU). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Over-the-counter test for rapid syphilis detection at home.

Home test for detecting pregnancy through hormone analysis.

Over-the-counter test for pregnancy in European markets.

People of NOWDiagnostics
Headcount 10-50
Employee Profiles 12
Board Members and Advisors 8
Employee Profiles
People
Kevin Clark
CEO
People
Gianni Furino
CEO, NOWDx Europe
People
Conner Veit
Product Development Scientist
People
Vicki Thompson
Director of Product Development

Unlock access to complete

Board Members and Advisors
people
Gregory H. Bledsoe
Advisor
people
Doug Degn
Director
people
Jeff Montie
Director
people
Charles Farkas
Director

Unlock access to complete

Funding Insights of NOWDiagnostics

NOWDiagnostics has successfully raised a total of $65.69M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $22.5 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series B — $22.5M
  • First Round

    (21 Mar 2013)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2024 Amount Series B - NOWDiagnostics Valuation DigitalDx Ventures , LabCorp
Dec, 2019 Amount Series A - NOWDiagnostics Valuation

investors

Jun, 2018 Amount Series A - NOWDiagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in NOWDiagnostics

NOWDiagnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, DigitalDX Ventures and Kompass Kapital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
DigitalDX Ventures is focused on AI and healthcare innovation investments.
Founded Year Domain Location
Private fund focused on debt, equity, and fund of funds investments
Founded Year Domain Location
Provider of laboratory tests for physicians
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by NOWDiagnostics

NOWDiagnostics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cellmic and ZBx Corporation. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Rapid test readers are developed for chromatographic and fluorescent assays.
2009
Point-of-care diagnostic products for clinical testing are developed and marketed.
2002
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - NOWDiagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nowdiagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of NOWDiagnostics

NOWDiagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, Avails Medical, Resistell, HandyLab and GNA Biosolutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of diagnostics and bioinformatics platforms for providers
domain founded_year HQ Location
Point-of-care devices are developed for infection diagnosis and treatment optimization.
domain founded_year HQ Location
Antibiotic susceptibility testing is provided via bacterial movement detection.
domain founded_year HQ Location
Molecular diagnostic assays and automation platforms are developed.
domain founded_year HQ Location
Instruments and assays for molecular pathogen detection are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nowdiagnostics

Frequently Asked Questions about NOWDiagnostics

When was NOWDiagnostics founded?

NOWDiagnostics was founded in 2013.

Where is NOWDiagnostics located?

NOWDiagnostics is headquartered in Bentonville, United States. It is registered at Bentonville, Arkansas, United States.

Is NOWDiagnostics a funded company?

NOWDiagnostics is a funded company, having raised a total of $65.69M across 5 funding rounds to date. The company's 1st funding round was a Series A of $13.25M, raised on Mar 21, 2013.

How many employees does NOWDiagnostics have?

As of Dec 31, 2022, the latest employee count at NOWDiagnostics is 28.

What does NOWDiagnostics do?

NowDiagnostics, formerly known as HomeDx develops and manufactures diagnostic tests that offer POC rapid test reader. Its ADEXUSDx product line uses a single drop of blood to test for a variety of common conditions, illnesses and diseases with quick results. It received FDA clearance for hCG test and is conducting two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests.

Who are the top competitors of NOWDiagnostics?

NOWDiagnostics's top competitors include Avails Medical, OpGen and Verax Biomedical.

What products or services does NOWDiagnostics offer?

NOWDiagnostics offers First To Know® Syphilis Test, ADEXUSDx® hCG Test, and First To Know® Pregnancy Test (EU).

How many acquisitions has NOWDiagnostics made?

NOWDiagnostics has made 2 acquisitions, including Cellmic, and ZBx Corporation.

Who are NOWDiagnostics's investors?

NOWDiagnostics has 3 investors. Key investors include LabCorp, DigitalDX Ventures, and Kompass Kapital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available